2017 – Page 22 – Policy & Medicine

Biotechnology Investors Beware?

The ACHA Passes the House

Novo Nordisk Settles Qui Tam Suit

Genentech Beats FCA Suit, Thanks to Escobar

Mylan Settlement Classified as “Too Low”

New Analysis Shows Out-of-Pocket Spending Based on List Price

Drug Shortages, Pricing, and Regulatory Activity

CHRONIC Care Act Reintroduced in the Senate

ExL Events to Host the 8th Aggregate Spend and Sunshine Act Conference

Senate HELP Hearing on FDA User Fee